Case Report: Hemophagocytic lymphohistiocytosis secondary to Escherichia coli infiltration of bone marrow in a patient with seronegative rheumatoid arthritis treated with low-dose methotrexate - Summary - MDSpire

Case Report: Hemophagocytic lymphohistiocytosis secondary to Escherichia coli infiltration of bone marrow in a patient with seronegative rheumatoid arthritis treated with low-dose methotrexate

  • By

  • Ziping Liu

  • Fengjian Li

  • Yunhong Liu

  • Xueyan Chen

  • July 13, 2026

Share

Objective:

To present a case of hemophagocytic lymphohistiocytosis (HLH) secondary to Escherichia coli infection in a seronegative rheumatoid arthritis patient on low-dose methotrexate.

Approach:
  • Diagnostic Evaluation: Bone marrow aspiration revealed active hemophagocytosis with phagocytosis of E. coli, confirming the diagnosis of HLH.
Key Findings:
  • The patient exhibited severe pancytopenia and systemic inflammation.
  • Bone marrow analysis showed 20% active hemophagocytosis with E. coli.
  • HLH was suspected due to elevated cytokine levels and laboratory abnormalities.
Interpretation:

The case highlights the potential for E. coli infections to induce HLH, particularly in immunocompromised patients.

Limitations:
  • The case is a single patient report, limiting generalizability.
  • Further studies are needed to understand the mechanisms linking E. coli to HLH.
Conclusion:

HLH can occur in the context of E. coli infections, especially in patients with underlying immunosuppression.

Original Source(s)

Related Content